Tourette's Syndrome Clinical Trial
Official title:
Integrative Examination of Neurobehavioral Mechanisms in Tic Suppression
The purpose of this study is to examine how the brain and environment interact to influence children's ability to suppress tics using a medical technology called Transcranial Magnetic Stimulation (TMS).
Objectives: This study will recruit youth with chronic tics. Chronic tics are the most common
movement disorder in children. The goal of the study is to learn how the brain and
environment influence children's ability to suppress tics. Specifically, we want to learn how
tics are influenced by a certain part of the brain called the supplementary motor area (SMA).
This part of the brain is thought to be more active in people with tics. This will be the
first study to look at the relationship between SMA, tic suppression, and urges to tic.
Research Procedures: The study will take place over the course of three days within a week
(about 5 hours total). The study will examine the relationship between the SMA and tic
suppression using a non-invasive medical technology called Transcranial Magnetic Stimulation
(TMS). Participants will have a diagnostic interview, MRI brain scan (used to find the
location of the SMA), and TMS. Participants will be asked to try to suppress tics before and
after TMS. The information that will be collected from participation includes information
about tic symptoms, emotional and behavioral functioning, and brain activity (from MRI brain
images and TMS results).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00965211 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome
|
N/A | |
Recruiting |
NCT00152750 -
Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD
|
Phase 4 | |
Completed |
NCT00241176 -
Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
|
Phase 4 | |
Terminated |
NCT00226824 -
Safety Study of Galantamine in Tic Disorders
|
Phase 4 | |
Completed |
NCT01244633 -
Ecopipam Treatment of Tourette Syndrome
|
Phase 1/Phase 2 | |
Recruiting |
NCT04805385 -
Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome
|
N/A | |
Completed |
NCT00026000 -
Brain Activation in Vocal and Motor Tics
|
N/A | |
Terminated |
NCT00001260 -
Brain Tissue Collection for Neuropathological Studies
|
||
Completed |
NCT02102698 -
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
|
Phase 2 | |
Withdrawn |
NCT02112253 -
Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome
|
Phase 1/Phase 2 | |
Withdrawn |
NCT01133353 -
A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
|
Phase 2 | |
Terminated |
NCT00282139 -
Aripiprazole in the Treatment of Tourette's Syndrome
|
N/A | |
Completed |
NCT03042507 -
Psychosocial Intervention for Young Children With Chronic Tics
|
N/A | |
Completed |
NCT01019343 -
Physiological Investigations of Movement Disorders
|
N/A | |
Completed |
NCT02619084 -
Subthalamic Stimulation in Tourette's Syndrome
|
Phase 2 | |
Completed |
NCT00368433 -
Hypersensitivity in Tourette Syndrome
|
N/A | |
Withdrawn |
NCT01475383 -
Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT06361004 -
Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome
|
N/A | |
Completed |
NCT00139308 -
High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome
|
Phase 1 |